![]() |
Volumn 325, Issue 2, 2021, Pages 184-186
|
Clinical Implications of Removing Race from Estimates of Kidney Function
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
CISPLATIN;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
METFORMIN;
SODIUM GLUCOSE COTRANSPORTER 2 INHIBITOR;
WARFARIN;
CREATININE;
ADULT;
BLACK PERSON;
CHRONIC KIDNEY FAILURE;
COHORT ANALYSIS;
CREATININE BLOOD LEVEL;
DIET THERAPY;
DISEASE SEVERITY;
ESTIMATED GLOMERULAR FILTRATION RATE;
FEMALE;
HEALTH EDUCATION;
HUMAN;
KIDNEY DONOR;
KIDNEY FUNCTION;
KIDNEY TRANSPLANTATION;
LETTER;
MAJOR CLINICAL STUDY;
MALE;
MEDICARE;
PATIENT CARE;
PREVALENCE;
PRIORITY JOURNAL;
RACE;
UNITED STATES;
AFRICAN AMERICAN;
ALGORITHM;
ANCESTRY GROUP;
BLOOD;
GLOMERULUS FILTRATION RATE;
KIDNEY;
NUTRITION;
PATHOPHYSIOLOGY;
ADULT;
AFRICAN AMERICANS;
ALGORITHMS;
CONTINENTAL POPULATION GROUPS;
CREATININE;
FEMALE;
GLOMERULAR FILTRATION RATE;
HUMANS;
KIDNEY;
MALE;
NUTRITION SURVEYS;
RENAL INSUFFICIENCY, CHRONIC;
|
EID: 85097420620
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2020.22124 Document Type: Letter |
Times cited : (110)
|
References (6)
|